Haas Jason
Ligand Pharmaceuticals Incorporated - Common Stock · Director
Haas Jason is listed in public filings as director. This Haas Jason insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Ligand Pharmaceuticals Incorporated - Common Stock (LGND), and Syros Pharmaceuticals, Inc. (SYRS). Investors use Haas Jason's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $613k5.8k shares | Grant / ExerciseJun 6, 2025 | $612.9K5.8k shares | $105.99 | -- | |
| --6.6k shares | Grant / ExerciseJun 6, 2025 | Disclosure amount unavailable1.2k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0137.8k shares | SellNov 18, 2024 | $29.0K137.8k shares | $0.2103 | -- | |
| --18.9k shares | Grant / ExerciseOct 31, 2024 | Disclosure amount unavailable18.9k shares | -- | -- | |
| $288k137.8k shares | Grant / ExerciseOct 31, 2024 | $11.8K5.6k shares | $2.09 | -- | |
| $209k124.6k shares | BuySep 12, 2024 | $76.0K45.3k shares | $1.68 | -- | |
| $125k79.2k shares | BuySep 11, 2024 | $30.4K19.3k shares | $1.58 | -- | |
| $93k59.9k shares | BuySep 10, 2024 | $54.8K35.4k shares | $1.55 | -- | |
| $436k5.4k shares | Grant / ExerciseJun 14, 2024 | $435.8K5.4k shares | $80.06 | -- | |
| --5.4k shares | Grant / ExerciseJun 14, 2024 | Disclosure amount unavailable1.3k shares | -- | -- |